Myocardial salvage efficacy of a thromboxane receptor antagonist, SQ, 30,741, in relation to inhibition ex vivo of platelet function in the ferret
- 1 September 1993
- journal article
- Published by Elsevier in Prostaglandins
- Vol. 46 (3) , 233-242
- https://doi.org/10.1016/0090-6980(93)90006-s
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy of a Monoclonal Antibody (MoAb 60.3) in Reducing Myocardial Injury Resulting from Ischemia/Reperfusion in the FerretJournal of Cardiovascular Pharmacology, 1991
- Use of the ferret for a myocardial ischemia/salvage modelJournal of Pharmacological Methods, 1990
- Reduction of Myocardial Damage and Polymorphonuclear Leukocyte Accumulation Following Coronary Artery Occlusion and Reperfusion by the Thromboxane Receptor Antagonist BM 13.505Journal of Cardiovascular Pharmacology, 1989
- Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in catsAmerican Heart Journal, 1989
- The Effect of the Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist SQ 30,741 on Myocardial Infarct Size and Blood Flow During Myocardial Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1988
- The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosisEuropean Journal of Pharmacology, 1988
- The Role of Thromboxane A2 in Reperfusion InjuryExperimental Biology and Medicine, 1988
- The Effects of L655,240, a Selective Thromboxane and Prostaglandin Endoperoxide Antagonist, on Ischemia- and Reperfusion-Induced Cardiac ArrhythmiasJournal of Cardiovascular Pharmacology, 1988
- Effect of the Thromboxane Receptor Antagonist SQ 29,548 on Myocardial Infarct Size in DogsJournal of Cardiovascular Pharmacology, 1988
- Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemiaEuropean Journal of Pharmacology, 1986